JAN PAWEL SKOWRONSKI

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology ROCKFORD, IL NPI 1790710283

General Payments — all program years on this page

$37,902.28

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 197
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $6,853.06 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $5,100.001
Food and Beverage $898.3314
Travel and Lodging $854.732

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $5,923.8471
2019 $2,243.6647
2020 $5,372.0322
2021 $1,078.325
2022 $612.9713
2023 $15,818.4022
2024 $6,853.0617

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087345499 Novartis Pharmaceuticals Corporation $21.05 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564218 Boston Scientific Corporation $2.05 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564220 Boston Scientific Corporation $3.26 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564222 Boston Scientific Corporation $5.78 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564224 Boston Scientific Corporation $100.04 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564226 Boston Scientific Corporation $105.09 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564228 Boston Scientific Corporation $137.56 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564230 Boston Scientific Corporation $212.80 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092564232 Boston Scientific Corporation $248.01 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092564234 Boston Scientific Corporation $641.93 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092564236 Boston Scientific Corporation $5,100.00 03/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093701449 Siemens Medical Solutions USA, Inc. $15.16 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093701451 Siemens Medical Solutions USA, Inc. $18.72 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095784992 Penumbra, Inc. $129.43 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132945866 ASAHI INTECC USA, INC. $60.04 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147708355 Thrombolex, Inc. $29.49 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154716518 Reflow Medical Inc $22.65 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.